| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |